Why the study?
To test whether aerobic exercise more effectively increases hippocampal blood flow in hypertensive APOE4 carriers than non-carriers.
Does a 52-week aerobic exercise intervention improve hippocampal blood flow in cognitively normal older adults with hypertension?
Does a 52-week aerobic exercise intervention improve hippocampal blood flow in cognitively normal older adults with hypertension?
Aerobic exercise significantly improves hippocampal blood flow in hypertensive APOE4 carriers, suggesting a targeted vascular benefit for individuals at high genetic risk for Alzheimer's disease.
May support prioritizing aerobic exercise for hypertensive APOE4 carriers; extends RCT evidence for genotype-specific cerebrovascular benefits in AD prevention.
Background Evidence increasingly suggests cerebrovascular dysfunction plays an early and important role in the pathogenesis of Alzheimer’s disease (AD). Studies have shown the strongest known genetic risk factor for sporadic AD, Apolipoprotein E4 ( APOE4 ), may act synergistically with vascular risk factors to promote dementia development. Aerobic exercise may attenuate cognitive decline at least partially through improvements in cerebral blood flow. Therefore, exercise interventions that improve vascular health may be particularly beneficial for APOE4 carriers. Objectives To test the hypothesis that exercise would more effectively increase hippocampal blood flow (HBF) in hypertensive APOE4 carriers than non-carriers, we performed an analysis of arterial spin labeling MRI data (ASL-MRI) from a randomized controlled trial (secondary outcome). Additionally, we tested the hypothesis that changes in systolic blood pressure (ΔSBP) would be more negatively associated with ΔHBF for APOE4 carriers than non-carriers. Methods We assigned cognitively normal adults (65–87 years) to a 52-week aerobic exercise intervention or education only. Genotyping was performed by Taqman SNP allelic discrimination assay. ASL-MRI measured HBF before and after the 52-week intervention. We selected participants with hypertension at enrollment (n = 44), defined as SBP ≥ 130mmHg or diastolic blood pressure (DBP) ≥ 80mmHg. Results A two-way ANCOVA showed a significant interaction between APOE4 carrier status and treatment group on change in HBF (ΔHBF) over the 52 weeks, controlling for age and sex ( p = 0.040). For APOE4 carriers, ΔHBF was significantly ( p = 0.006) higher for participants who underwent the exercise intervention (4.09 mL/100g/min) than for the control group (−2.08 mL/100g/min). There was no difference in ΔHBF between the control (−0.32 mL/100g/min) and exercise (−0.54 mL/100g/min) intervention groups for APOE4 non-carriers (p = 0.918). Additionally, a multiple linear regression showed a significant interaction between ΔSBP and APOE4 carrier status on ΔHBF ( p = 0.035), with a reduction in SBP associated with an increase in HBF for APOE4 carriers only. Conclusions Aerobic exercise significantly improved HBF for hypertensive APOE4 carriers only. Additionally, only APOE4 carriers exhibited an inverse relationship between ΔSBP and ΔHBF. This suggests exercise interventions, particularly those that lower SBP, may be beneficial for individuals at highest genetic risk of AD.
No takes yet. Share an insight, caveat, or question.
Kaufman et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: